• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS. Versailles 2nd Consensus Conference participants.

作者信息

Brooks B R

机构信息

University of Wisconsin Hospital & Clinics, ALS Clinical Research Center, Madison 53792-5132, USA.

出版信息

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S79-81. doi: 10.1080/14660820050515629.

DOI:10.1080/14660820050515629
PMID:11464934
Abstract

The 2nd Consensus Conference (Versailles) recommended that an ALS knowledge-base for initial healthcare providers, diagnosing neurologists and confirming neurologists should be defined to include a simplified version of diagnostic criteria less formal than the World Federation of Neurology El Escorial Revisted Criteria ('ALS diagnosis - An algorithm'), a set of rules concerning red flags which should increase the suspicion of ALS as the diagnosis and minimize the time between suspicion and referral for confirmation of diagnosis ('ALS axioms of referral'), as well as a site of symptom onset-specific checklist of minimal clinical examination, neuroimaging, electrodiagnostic, pulmonary function and laboratory test information required to confirm the diagnosis of ALS ('Versailles minimal dataset'). Although introductory discussions addressed the advantages and disadvantages of earlier diagnosis, false-positive or false-negative diagnosis, the frequency of follow-up and what potential biological markers to be followed, these issues will have to be further evaluated at future consensus conferences.

摘要

相似文献

1
Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS. Versailles 2nd Consensus Conference participants.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S79-81. doi: 10.1080/14660820050515629.
2
Problems in shortening the time to confirmation of ALS diagnosis: lessons from the 1st Consensus Conference, Chicago, May 1998.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S3-7. doi: 10.1080/146608200300079987.
3
ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?再探埃斯科里亚尔肌萎缩侧索硬化症诊断标准:它们是否满足临床医生和研究人员的需求?
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S57-60. doi: 10.1080/14660820052415925.
4
Shortening the time to the diagnosis of amyotrophic lateral sclerosis: role of the neurologist.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S65-6. doi: 10.1080/14660820050515584.
5
Confounding effects of mimicking disorders in the early diagnosis of amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S61-3. doi: 10.1080/14660820050515773.
6
[Cerebellar symptoms in motor neuron diseases. Special form of amyotrophic lateral sclerosis plus syndrome].[运动神经元病中的小脑症状。肌萎缩侧索硬化加综合征的特殊形式]
Nervenarzt. 2002 Aug;73(8):751-3. doi: 10.1007/s00115-002-1343-y.
7
Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: the Lambert and the El Escorial criteria.临床神经生理学在肌萎缩侧索硬化症诊断中的应用:兰伯特标准与埃尔埃斯科里亚尔标准
J Neurol Sci. 1998 Oct;160 Suppl 1:S25-9. doi: 10.1016/s0022-510x(98)00194-4.
8
Electrodiagnostic approach to the patient with suspected motor neuron disease.
Neurol Clin. 2002 May;20(2):527-55, viii. doi: 10.1016/s0733-8619(01)00011-1.
9
[Electrodiagnostic criteria for early diagnosis of bulbar-onset ALS: a comparison of El Escorial, revised El Escorial and Awaji algorithm].[球部起病型肌萎缩侧索硬化症早期诊断的电诊断标准:埃尔埃斯科里亚尔标准、修订的埃尔埃斯科里亚尔标准与阿波岐算法的比较]
Rev Neurol (Paris). 2014 Feb;170(2):134-9. doi: 10.1016/j.neurol.2013.10.004. Epub 2013 Nov 14.
10
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group.迈向肌萎缩侧索硬化症的早期诊断:修订标准。rhCNTF肌萎缩侧索硬化症研究小组。
Neurology. 1998 Mar;50(3):768-72. doi: 10.1212/wnl.50.3.768.

引用本文的文献

1
Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中上下运动神经元受累情况及其对疾病预后的影响。
Neural Regen Res. 2022 Jan;17(1):65-73. doi: 10.4103/1673-5374.314289.
2
Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.血清视黄醇结合蛋白 4 浓度与肌萎缩侧索硬化症风险和预后的关联。
JAMA Neurol. 2018 May 1;75(5):600-607. doi: 10.1001/jamaneurol.2017.5129.
3
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
生命历程体重指数与肌萎缩侧索硬化症的风险和预后:来自 ALS 登记处 Swabia 的结果。
Eur J Epidemiol. 2017 Oct;32(10):901-908. doi: 10.1007/s10654-017-0318-z. Epub 2017 Oct 3.
4
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.脂肪细胞因子、C 反应蛋白与肌萎缩侧索硬化症——来自德国人群肌萎缩侧索硬化症注册登记研究的结果。
Sci Rep. 2017 Jun 29;7(1):4374. doi: 10.1038/s41598-017-04706-5.
5
Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.新的突变支持丝切蛋白1在肌萎缩侧索硬化症发病机制中的作用。
Neurobiol Aging. 2015 Mar;36(3):1602.e17-27. doi: 10.1016/j.neurobiolaging.2014.10.032. Epub 2014 Oct 31.
6
Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.德国南部肌萎缩侧索硬化症(ALS)的发病率及地理差异——施瓦本ALS登记处的完整性
PLoS One. 2014 Apr 10;9(4):e93932. doi: 10.1371/journal.pone.0093932. eCollection 2014.
7
Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia.基于人群的罕见病流行病学登记处的实施:肌萎缩侧索硬化症(ALS)——Swabia 登记处的研究方案。
BMC Neurol. 2013 Feb 17;13:22. doi: 10.1186/1471-2377-13-22.